Malcolm Sacco has recently been appointed Head of Research and Development at Medichem, a pharmaceutical company specialising in the development and manufacture of Active Pharmaceutical Ingredient (APIs) and Finished Dosage Forms (FDFs) for the global generics industry.
At the start of his career, Mr Sacco worked at Medichem for over seven years, beginning as a Quality Control Laboratory Analyst in 2011 and later serving as a Research and Development Officer. In 2018, he left Medichem to gain experience with Siegfried Holding AG and A2W Pharma.
In 2020, Mr Sacco rejoined Medichem as an FDF Industrialisation Manager.
In his new role, Mr Sacco will be managing technology transfer, overseeing development projects, and providing scientific guidance. He will also lead a team of scientists, manage laboratories, and evaluate manufacturing opportunities.
Featured Image:
Facebook and Linkedin / Malcolm Sacco
Senior journalist Kevin Schembri Orland reflects on the family-friendly measures electoral proposals, and the need to overcome the challenges they ...
Malta is no longer an economy searching for growth.
In founder-led businesses, effective management depends on balancing entrepreneurial instinct with the structure needed for sustainable growth.
Long-serving executive steps into COO role, bringing over a decade of experience across operations, investor relations and corporate governance.